GenovisB and d evitria AG signed a service agreement to offer eviia's customers fast LC-MS characterizatioion of recombinant antibodies using Genovis proprietary enzyme technologies. evitria AG is a world leading service provider for recombinant antibody expression in CHO cells with headquarters in Zürich, Switzerland. With this new service agreement, Genovis expands into a new business area that combines the ease of use of the SmartEnzymes[TM] with the competence and experience in the Genovis team to make advanced LC-MS analytics of recombinant antibodies available to a broader market.

This agreement is a starting point for Genovis ambitions to offer advanced automated LC-MS analytical services to biopharma customers where the underlying trend to outsource research and development activities continues to grow.